giant cell glioblastoma

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • bevacizumab
  • +5 more
  • Los Angeles, California
  • +2 more
Feb 10, 2022

Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

Completed
  • Glioblastoma
  • +3 more
  • Unpulsed DCs
  • +6 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 3, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 3, 2021

Giant Cell Glioblastoma, Gliosarcoma, Oligodendroglioma Trial in Los Angeles (autologous dendritic cells pulsed with tumor

Withdrawn
  • Giant Cell Glioblastoma
  • +4 more
  • autologous dendritic cells pulsed with tumor lysate antigen Vaccine
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

18F-FEC for Positron Emission Tomography-Computed Tomography

Withdrawn
  • Astrocytoma, Grade IV
  • +2 more
  • (no location specified)
Jul 21, 2020

Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +12 more
  • 3-Dimensional Conformal Radiation Therapy
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 17, 2019

Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

Terminated
  • Anaplastic Astrocytoma
  • +8 more
  • imetelstat sodium
  • Los Angeles, California
  • +10 more
Jun 20, 2018

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

Completed
  • Glioblastoma
  • +4 more
  • Rindopepimut (CDX-110) with GM-CSF
  • +2 more
  • Birmingham, Alabama
  • +222 more
Jan 11, 2018

Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

Completed
  • Teratoid Tumor, Atypical
  • +9 more
  • azurin-derived cell-penetrating peptide p28
  • Los Angeles, California
  • +10 more
Aug 3, 2017

Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma Trial in United States (XL184, temozolomide, Radiation Therapy)

Completed
  • Glioblastoma
  • +2 more
  • Los Angeles, California
  • +7 more
Sep 19, 2014

Brain Tumor, Anaplastic Astrocytoma, Anaplastic Ependymoma Trial in Cleveland (ritonavir, lopinavir)

Terminated
  • Brain Tumor
  • +8 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
Apr 24, 2013